APTA-1004

N/A

Report date: 2025/06/11 10:43:15
NME

Base Information

Drug NameAPTA-1004
Drug Alias NameAPX-1004APTA-1004
ClassificationSmall molecules
Mechanisms of ActionNADPH oxidase inhibitors
TargetsNADPH oxidase
Therapy Area/IndicationsDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAptabio Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAptabio Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDiabetic Retinopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A